Besides, individuals with colorectal cancer who had high GLS1 expression demonstrated a reduced overall survival, and breast cancer patients with high GLS1 expression experienced a shorter Recurrence Free Survival (RFS) (Figure S14A,B). Here, GLS is linked to breast carcinoma.